supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
Research Papers that Mention the Interaction
“Change in HbA(1c) at 26 weeks was greater in patients taking exenatide (n=228; -1.5%, SE 0.05) than in those taking insulin glargine (n=220; -1.3%, 0.06; treatment difference -0.16%, 0.07, 95% CI -0.29 to -0.03).”
Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial“The primary outcomes, area under the curve over 240 minutes (AUC 240) for blood glucose (P < 0.0001) and peak blood glucose (7.65 mM ± 0.34 [mean ± SE ] vs 9.53 mM ± 0.63, P < 0.0001), were markedly lower after exenatide than placebo.”
“FINDINGS At 30 weeks, the patients given ex natide on ce a week had significantly greater changes in HbA(1c) than those given exenatide twice a day (-1.9 [SE 0. 1%] vs -1.5 [0.1%], 95% CI -0.54% to -0.12%; p=0.0023).”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback